L7-2 Antihyperglycemic Therapy and Cardiovascular Disease: In Search of the Holy Grail

Program: Plenary
Session: L7-Sunday Morning Plenary
Silvio E Inzucchi, MD
Yale School of Medicine, New Haven, CT
Talk Description:

The link between Type 2 diabetes and cardiovascular disease will be reviewed and placed into the context of the multiplicity of risk factors often encountered in this disease. The impact of glucose lowering therapy on cardiovascular events will next be described, both as regards to HbA1c targets and specific therapeutic classes. Ongoing clinical trials examining this important clinical question will be also discussed.

Disclosure: SEI: Research Materials, Takeda, Speaker, Astra Zeneca, Scientific Board Member, Eisai, Scientific Board Member, Lexicon Pharmaceuticals, Inc., Committee Member, Intarcia, Scientific Board Member, Boehringer-Ingelheim, Committee Member, Novo Nordisk, Planning Group Member, Merck & Co..
See more of: Sunday Morning Plenary
See more of: Plenary
<< Previous Talk | Next Talk